Breakthrough Cancer Therapy Stalls in Manufacturing Bottleneck

February 20, 2019

Drug companies like GlaxoSmithKline Plc and Gilead are banking on cutting-edge cancer treatments known as CAR-T, but manufacturing bottlenecks are holding back the market.

Related Stories